Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (English)

This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national health reform process. The present paper builds upon earlier critical reviews and other papers published in the series china health policy notes. The paper is divided into four parts. The first section provides an overview of the Chinese pharmaceutical...

Document also available in : English, Chinese, Chinese

DETAILS

Author

Hu,Shanlian;
Document Date
2010/06/01
Document Type
Working Paper (Numbered Series)
Report Number
58410
Volume No
2
Total Volume(s)
2 (See all volumes)
Country
China,
Region
East Asia and Pacific,
Disclosure Date
2010/12/14
Disclosure Status
Disclosed
Doc Name
Main report
Keywords
essential medicines

DOWNLOADS

COMPLETE REPORT

Official version of document (may contain signatures, etc)

Official PDF
TXT*
Download Stats
*The text version is uncorrected OCR text and is included solely to benefit users with slow connectivity.

Citation

Hu,Shanlian.

Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (English). China health policy notes ; no. 1 Washington, DC: World Bank. http://documents.worldbank.org/curated/en/933311468216270181

Financing, pricing, and utilization of pharmaceuticals in China : the road to reform policy (Vol. 2 of 2) : Main report (English)

DETAILS

DOWNLOADS

COMPLETE REPORT

Citation

RELATED LINKS

SUBSCRIBE TO EMAIL ALERTS